From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease

Poupon, 2000, Chronic cholestatic diseases, J. Hepatol., 32, 129, 10.1016/S0168-8278(00)80421-3 Eslam, 2020, A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement, J Hepatol Eslam, 2020, MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease, Gastroenterology, 158, 1999, 10.1053/j.gastro.2019.11.312 Horner, 2016, Hepatocyte isolation after laparoscopic liver resection, Tissue Eng. Part C Methods, 22, 839, 10.1089/ten.tec.2016.0187 Iansante, 2018, Human hepatocyte transplantation for liver disease: current status and future perspectives, Pediatr. Res., 83, 232, 10.1038/pr.2017.284 Strom, 1982, Isolation, culture, and transplantation of human hepatocytes, J. Natl Cancer Inst., 68, 771 Hewitt, 2007, Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies, Drug Metab. Rev., 39, 159, 10.1080/03602530601093489 Hengstler, 2000, Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction, Drug Metab. Rev., 32, 81, 10.1081/DMR-100100564 Xiang, 2019, Long-term functional maintenance of primary human hepatocytes in vitro, Science, 364, 399, 10.1126/science.aau7307 Gómez-Lechón, 2014, Competency of different cell models to predict human hepatotoxic drugs, Expert Opin. Drug Metab. Toxicol., 10, 1553, 10.1517/17425255.2014.967680 Boess, 2003, Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems, Toxicol. Sci., 73, 386, 10.1093/toxsci/kfg064 Godoy, 2013, Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME, Arch. Toxicol., 87, 1315, 10.1007/s00204-013-1078-5 LeCluyse, 2001, Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation, Eur. J. Pharm. Sci., 13, 343, 10.1016/S0928-0987(01)00135-X Ansede, 2010, An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes, Drug Metab. Dispos., 38, 276, 10.1124/dmd.109.028407 Chatterjee, 2014, Hepatocyte-based in vitro model for assessment of drug-induced cholestasis, Toxicol. Appl. Pharmacol., 274, 124, 10.1016/j.taap.2013.10.032 Oorts, 2016, Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes, Toxicol. In Vitro, 34, 179, 10.1016/j.tiv.2016.03.008 Swift*, B., N.D. Pfeifer*, and K.L. Brouwer, Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug metabolism reviews, 2010. 42(3): p. 446-471. Kazankov, 2019, The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, Nat. Rev. Gastroenterol. Hepatol., 16, 145, 10.1038/s41575-018-0082-x Wanninger, J., M. Neumeier, C. Hellerbrand, D. Schacherer, S. Bauer, T.S. Weiss, et al., Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2011. 1811(10): p. 626-633. Kirovski, 2010, Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation, Int. J. Clin. Exp. Path., 3, 675 Wobser, 2009, Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells, Cell Res., 19, 996, 10.1038/cr.2009.73 Davidson, 2016, Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes, Sci. Rep., 6, 28178, 10.1038/srep28178 Kim, 2019, Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells, J. Hepatol., 70, 97, 10.1016/j.jhep.2018.09.007 Fu, 2019, Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens, Cell Res., 29, 8, 10.1038/s41422-018-0103-x Zhang, 2018, Sun, et al., In vitro expansion of primary human hepatocytes with efficient liver repopulation capacity, Cell Stem Cell, 23, 806, 10.1016/j.stem.2018.10.018 Bell, 2016, Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease, Sci. Rep., 6, 25187, 10.1038/srep25187 Grompe, 2013, Mice with human livers, Gastroenterology, 145, 1209, 10.1053/j.gastro.2013.09.009 Rhim, 1994, Replacement of diseased mouse liver by hepatic cell transplantation, Science, 263, 1149, 10.1126/science.8108734 Strom, 2010, Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity, Methods Mol Biol, 640, 491, 10.1007/978-1-60761-688-7_27 Castell, 2006, Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies, Expert Opin. Drug Metab. Toxicol., 2, 183, 10.1517/17425255.2.2.183 Guo, 2011, Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes, Drug Metab. Dispos., 39, 528, 10.1124/dmd.110.035873 Yokoo, 2004, Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells, Hepatology, 40, 609, 10.1002/hep.20372 Gerets, 2012, Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins, Cell Biol. Toxicol., 28, 69, 10.1007/s10565-011-9208-4 M.-J. Marion O. Hantz D. Durantel The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies Hepatocytes 2010 Springer 261 272. Nelson, 2017, Human Hepatic Hepa RG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP 450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications, Basic Clin. Pharmacol. Toxicol., 120, 30, 10.1111/bcpt.12631 Kanebratt, 2008, Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies, Drug Metab. Dispos., 36, 1444, 10.1124/dmd.107.020016 Sison-Young, 2015, Comparative proteomic characterization of 4 human liver-derived single cell culture models reveals significant variation in the capacity for drug disposition, bioactivation, and detoxication, Toxicol. Sci., 147, 412, 10.1093/toxsci/kfv136 Anthérieu, 2013, Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells, Hepatology, 57, 1518, 10.1002/hep.26160 Grünig, 2018, Effect of the catechol-O-methyltransferase inhibitors tolcapone and entacapone on fatty acid metabolism in HepaRG cells, Toxicol. Sci., 164, 477, 10.1093/toxsci/kfy101 Grünig, 2020, Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms, Biochem. Pharmacol., 10.1016/j.bcp.2020.113860 Ihrke, 1993, WIF-B cells: an in vitro model for studies of hepatocyte polarity, The Journal of Cell Biology, 123, 1761, 10.1083/jcb.123.6.1761 Mersch-Sundermann, 2004, Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents, Toxicology, 198, 329, 10.1016/j.tox.2004.02.009 Gonzalez-Rubio, 2016, M. de la Mata, et al., AP-1 inhibition by SR 11302 protects human Hepatoma HepG2 cells from bile acid-induced Cytotoxicity by restoring the NOS-3 expression, PLoS ONE, 11, 10.1371/journal.pone.0160525 Woolbright, 2015, Critical factors in the assessment of cholestatic liver injury in vitro, 363 Denk, 2012, Tauro-β-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential, Biochem. Biophys. Res. Commun., 424, 758, 10.1016/j.bbrc.2012.07.029 Ricchi, 2009, Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes, J. Gastroenterol. Hepatol., 24, 830, 10.1111/j.1440-1746.2008.05733.x Ramboer, 2015, Immortalized human hepatic cell lines for in vitro testing and research purposes, 53 De Gottardi, 2007, Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes, Lab. Invest., 87, 792, 10.1038/labinvest.3700590 Martel, 2013, Glycogen synthase kinase 3-mediated voltage-dependent anion channel phosphorylation controls outer mitochondrial membrane permeability during lipid accumulation, Hepatology, 57, 93, 10.1002/hep.25967 Grubman, 1994, Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines, Am J Physiol, 266, G1060 Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 Liu, 2020, Advances in pluripotent stem cells: history, mechanisms, technologies, and applications, Stem cell reviews and reports, 16, 3, 10.1007/s12015-019-09935-x Hannan, 2013, Production of hepatocyte-like cells from human pluripotent stem cells, Nat. Protoc., 8, 430, 10.1038/nprot.2012.153 Roelandt, 2013, Directed differentiation of pluripotent stem cells to functional hepatocytes, 141 Sancho-Bru, 2011, Directed differentiation of murine-induced pluripotent stem cells to functional hepatocyte-like cells, J. Hepatol., 54, 98, 10.1016/j.jhep.2010.06.014 Si-Tayeb, 2010, Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells, Hepatology, 51, 297, 10.1002/hep.23354 Song, 2009, Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells, Cell Res., 19, 1233, 10.1038/cr.2009.107 Takata, 2011, Direct differentiation of hepatic cells from human induced pluripotent stem cells using a limited number of cytokines, Hep. Intl., 5, 890, 10.1007/s12072-011-9251-5 Böhm, 2010, Regulation of liver regeneration by growth factors and cytokines, EMBO Mol. Med., 2, 294, 10.1002/emmm.201000085 Asumda, 2018, Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules, Differentiation, 101, 16, 10.1016/j.diff.2018.03.002 Du, 2018, Highly efficient and expedited hepatic differentiation from human pluripotent stem cells by pure small-molecule cocktails, Stem Cell Res. Ther., 9, 58, 10.1186/s13287-018-0794-4 Siller, 2015, Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells, Stem Cell Rep., 4, 939, 10.1016/j.stemcr.2015.04.001 Boon, 2020, Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines, Nat. Commun., 11, 1, 10.1038/s41467-020-15058-6 Inamura, 2011, Efficient generation of hepatoblasts from human ES cells and iPS cells by transient overexpression of homeobox gene HEX, Mol. Ther., 19, 400, 10.1038/mt.2010.241 Oh, 2019, Directed differentiation of pluripotent stem cells by transcription factors, Mol. Cells, 42, 200 Takayama, 2012, Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction, Mol. Ther., 20, 127, 10.1038/mt.2011.234 Tomizawa, 2016, Transcription factors and medium suitable for initiating the differentiation of human-induced pluripotent stem cells to the hepatocyte lineage, J. Cell. Biochem., 117, 2001, 10.1002/jcb.25494 Gieseck, 2014, Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture, PLoS ONE, 9 Takebe, 2017, Massive and reproducible production of liver buds entirely from human pluripotent stem cells, Cell reports, 21, 2661, 10.1016/j.celrep.2017.11.005 Takebe, 2014, Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant, Nat. Protoc., 9, 396, 10.1038/nprot.2014.020 Danoy, 2019, Optimized protocol for the hepatic differentiation of induced pluripotent stem cells in a fluidic microenvironment, Biotechnol. Bioeng., 116, 1762, 10.1002/bit.26970 M. Parafati R.J. Kirby S. Khorasanizadeh F. Rastinejad S. Malany A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis Disease models & mechanisms 11 9 2018 p. dmm033530. Ouchi, 2019, Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids, Cell Metab, 30, 374, 10.1016/j.cmet.2019.05.007 Maepa, 2020, Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases, Stem Cells, 38, 606, 10.1002/stem.3154 Dianat, 2014, Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells, Hepatology, 60, 700, 10.1002/hep.27165 Ogawa, 2015, Directed differentiation of cholangiocytes from human pluripotent stem cells, Nat. Biotechnol., 33, 853, 10.1038/nbt.3294 Sampaziotis, 2017, Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids, Nat. Med., 23, 954, 10.1038/nm.4360 Sampaziotis, 2015, Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation, Nat. Biotechnol., 33, 845, 10.1038/nbt.3275 Stanger, 2015, Cellular homeostasis and repair in the mammalian liver, Annu. Rev. Physiol., 77, 179, 10.1146/annurev-physiol-021113-170255 Font-Burgada, 2015, Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer, Cell, 162, 766, 10.1016/j.cell.2015.07.026 Wang, 2015, Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver, Nature, 524, 180, 10.1038/nature14863 Aizarani, 2019, A Human Liver Cell Atlas: Revealing Cell Type Heterogeneity and Adult Liver Progenitors by Single-Cell RNA-sequencing, bioRxiv Aloia, 2019, Epigenetic remodelling licences adult cholangiocytes for organoid formation and liver regeneration, Nat. Cell Biol., 21, 1321, 10.1038/s41556-019-0402-6 Huch, 2015, Long-term culture of genome-stable bipotent stem cells from adult human liver, Cell, 160, 299, 10.1016/j.cell.2014.11.050 Prior, 2019, Lgr5+ stem and progenitor cells reside at the apex of a heterogeneous embryonic hepatoblast pool, Development, 146, 174557, 10.1242/dev.174557 Hu, 2018, Long-term expansion of functional mouse and human hepatocytes as 3D organoids, Cell, 175, 1591, 10.1016/j.cell.2018.11.013 W.C. Peng C.Y. Logan M. Fish T. Anbarchian F. Aguisanda A. Álvarez-Varela et al. Inflammatory cytokine TNFα promotes the long-term expansion of primary hepatocytes in 3D culture Cell 175 6 2018 pp. 1607–1619. e15. Kruitwagen, 2017, Long-term adult feline liver organoid cultures for disease modeling of hepatic steatosis, Stem Cell Rep., 8, 822, 10.1016/j.stemcr.2017.02.015 Greene, 2016, α1-Antitrypsin deficiency, Nat. Rev. Dis. Primers, 2, 16051, 10.1038/nrdp.2016.51 Gómez-Mariano, 2020, Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease, Hep. Intl., 14, 127, 10.1007/s12072-019-10007-y Broutier, 2017, Human primary liver cancer–derived organoid cultures for disease modeling and drug screening, Nat. Med., 23, 1424, 10.1038/nm.4438 Afshari, 2020, Different approaches for transformation of mesenchymal stem cells into hepatocyte-like cells, Stem Cell Res. Ther., 11, 54, 10.1186/s13287-020-1555-8 Yin, 2015, Adipose tissue-derived mesenchymal stem cells differentiated into hepatocyte-like cells in vivo and in vitro, Mol. Med. Rep., 11, 1722, 10.3892/mmr.2014.2935 Yoon, 2010, In vitro hepatic differentiation of umbilical cord-derived mesenchymal stem cell, Process Biochem., 45, 1857, 10.1016/j.procbio.2010.06.009 Zheng, 2015, Differentiation of human umbilical cord-derived mesenchymal stem cells into hepatocytes in vitro, Bio-Med. Mater. Eng., 25, 145, 10.3233/BME-141249 Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905 Yu, 2018, Differentiation of umbilical cord mesenchymal stem cells into hepatocytes in comparison with bone marrow mesenchymal stem cells, Mol. Med. Rep., 18, 2009 Li, 2019, Functional 3D human liver bud assembled from MSC-derived multiple liver cell lineages, Cell Transplant., 28, 510, 10.1177/0963689718780332 Rimland, 2020, Regional differences in human biliary tissues and corresponding in vitro derived organoids, Hepatology, 10.1002/hep.31252 Soroka, 2019, Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile, Hepatology, 70, 871, 10.1002/hep.30470 Merrell, 2016, Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style, Nat. Rev. Mol. Cell Biol., 17, 413, 10.1038/nrm.2016.24 Gratte, 2018, Transdifferentiation of pancreatic progenitor cells to hepatocyte-like cells is not serum-dependent when facilitated by extracellular matrix proteins, Sci. Rep., 8, 1, 10.1038/s41598-018-22596-z Huang, 2014, Direct reprogramming of human fibroblasts to functional and expandable hepatocytes, Cell Stem Cell, 14, 370, 10.1016/j.stem.2014.01.003 Simeonov, 2014, Direct reprogramming of human fibroblasts to hepatocyte-like cells by synthetic modified mRNAs, PLoS ONE, 9, 10.1371/journal.pone.0100134 Chen, 2018, Biotechnology challenges to in vitro maturation of hepatic stem cells, Gastroenterology, 154, 1258, 10.1053/j.gastro.2018.01.066 Kogiso, 2013, Transdifferentiation of human fibroblasts into hepatocyte-like cells by defined transcriptional factors, Hep. Intl., 7, 937, 10.1007/s12072-013-9432-5 Ni, 2016, Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: a novel in vitro cholestatic model, Sci. Rep., 6, 38694, 10.1038/srep38694 Cole, 2018, Non-alcoholic fatty liver disease (NAFLD) models in drug discovery, Expert Opin. Drug Discov., 13, 193, 10.1080/17460441.2018.1410135 Kanamori, 2018, Technical aspects of microphysiological systems (MPS) as a promising wet human-in-vivo simulator, Drug Metab. Pharmacokinet., 33, 40, 10.1016/j.dmpk.2017.11.006 Kimura, 2018, Organ/body-on-a-chip based on microfluidic technology for drug discovery, Drug Metab. Pharmacokinet., 33, 43, 10.1016/j.dmpk.2017.11.003 Zhang, 2018, Advances in organ-on-a-chip engineering, Nat. Rev. Mater., 3, 257, 10.1038/s41578-018-0034-7 Foster, 2019, Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid, Arch. Toxicol., 93, 1021, 10.1007/s00204-019-02427-4 Jang, 2019, Reproducing human and cross-species drug toxicities using a Liver-Chip, Sci. Transl. Med., 11, 10.1126/scitranslmed.aax5516 Hassan, 2020, Liver-on-a-Chip Models of Fatty Liver Disease, Hepatology, 10.1002/hep.31106 Jochems, 2019, Development and validation of bioengineered intestinal tubules for translational research aimed at safety and efficacy testing of drugs and nutrients, Toxicol. In Vitro, 60, 1, 10.1016/j.tiv.2019.04.019 Chevtchik, 2016, Upscaling of a living membrane for bioartificial kidney device, Eur. J. Pharmacol., 790, 28, 10.1016/j.ejphar.2016.07.009 Jansen, 2015, Human proximal tubule epithelial cells cultured on hollow fibers: living membranes that actively transport organic cations, Sci. Rep., 5, 16702, 10.1038/srep16702 Verma, 2018, Three-dimensional multiscale fiber matrices: development and characterization for increased HepG2 functional maintenance for bio-artificial liver application, Biomater. Sci., 6, 280, 10.1039/C7BM00963A Ahmed, 2017, 3D liver membrane system by co-culturing human hepatocytes, sinusoidal endothelial and stellate cells, Biofabrication, 9, 10.1088/1758-5090/aa70c7 Chen, 2018, Bioengineered bile ducts recapitulate key cholangiocyte functions, Biofabrication, 10, 10.1088/1758-5090/aac8fd Tostoes, 2012, Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing, Hepatology, 55, 1227, 10.1002/hep.24760 Hendriks, 2016, Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability, Sci. Rep., 6, 35434, 10.1038/srep35434 Kozyra, 2018, Human hepatic 3D spheroids as a model for steatosis and insulin resistance, Sci. Rep., 8, 1, 10.1038/s41598-018-32722-6 Warburg, O., Versuche an überlebendem karzinomgewebe. 1923: Biochem Z. . p. 317-333. Krumdieck, 1980, A new instrument for the rapid preparation of tissue slices, Anal. Biochem., 104, 118, 10.1016/0003-2697(80)90284-5 De Graaf, 2010, Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies, Nat. Protoc., 5, 1540, 10.1038/nprot.2010.111 Bigaeva, 2019, Transcriptomic characterization of culture-associated changes in murine and human precision-cut tissue slices, Arch. Toxicol., 93, 3549, 10.1007/s00204-019-02611-6 Palma, 2019, Precision-cut liver slices: a versatile tool to advance liver research, Hep. Intl., 13, 51, 10.1007/s12072-018-9913-7 Vatakuti, 2017, Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach, Arch. Toxicol., 91, 1401, 10.1007/s00204-016-1778-8 Eshmuminov, 2020, An integrated perfusion machine preserves injured human livers for 1 week, Nat Biotechnol, 38, 189, 10.1038/s41587-019-0374-x Nasralla, 2018, A randomized trial of normothermic preservation in liver transplantation, Nature, 557, 50, 10.1038/s41586-018-0047-9 Jayant, 2018, Normothermic ex-vivo liver perfusion: where do we stand and where to reach?, Expert review of gastroenterology & hepatology, 12, 1045, 10.1080/17474124.2018.1505499 Ravikumar, 2015, Normothermic liver preservation: a new paradigm?, Transpl. Int., 28, 690, 10.1111/tri.12576 Weissenbacher, 2019, The future of organ perfusion and re-conditioning, Transpl. Int., 32, 586, 10.1111/tri.13441 Grosse-Siestrup, 2001, The isolated perfused liver: a new model using autologous blood and porcine slaughterhouse organs, J. Pharmacol. Toxicol. Methods, 46, 163, 10.1016/S1056-8719(02)00184-3 Grosse-Siestrup, 2002, Isolated hemoperfused slaughterhouse livers as a valid model to study hepatotoxicity, Toxicol. Pathol., 30, 749, 10.1080/01926230290166841 Jamieson, 2011, Hepatic steatosis and normothermic perfusion—preliminary experiments in a porcine model, Transplantation, 92, 289, 10.1097/TP.0b013e318223d817 Nagrath, 2009, Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo, Metab. Eng., 11, 274, 10.1016/j.ymben.2009.05.005 Mariotti, 2018, Animal models of biliary injury and altered bile acid metabolism, Biochim. Biophys. Acta (BBA)-Mol. Basis Disease, 1864, 1254, 10.1016/j.bbadis.2017.06.027 Pose, 2019, 3, 5-Diethoxycarbonyl-1, 4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research, 249 Cai, S.-Y., M. Ge, A. Mennone, R. Hoque, X. Ouyang, and J.L. Boyer, Inflammasome is activated in the liver of cholestatic patients and aggravates hepatic injury in bile duct ligated mouse. Cellular and Molecular Gastroenterology and Hepatology, 2019. Heinrich, 2011, Partial bile duct ligation in mice: a novel model of acute cholestasis, Surgery, 149, 445, 10.1016/j.surg.2010.07.046 Yokota, 2018, Partial bile duct ligation in the mouse: a controlled model of localized obstructive cholestasis, JoVE (J. Visual. Exp.), 133 Hertel, 2013, Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles, Vaccine, 31, 5778, 10.1016/j.vaccine.2013.07.023 K. Lorent W. Gong K.A. Koo O. Waisbourd-Zinman S. Karjoo X. Zhao et al. Identification of a plant isoflavonoid that causes biliary atresia Sci Transl Med 7 286 2015 p. 286ra67. Marrone, 2019, Improved hepatic MRP2/ABCC2 transport activity in LPS-induced cholestasis by aquaporin-1 gene transfer, Biochimie, 165, 179, 10.1016/j.biochi.2019.07.027 Baker, 2019, Systematic review of progressive familial intrahepatic cholestasis, Clinics Res. Hepatol. Gastroenterol., 43, 20, 10.1016/j.clinre.2018.07.010 Himes, 2020, NR1H4-related Progressive Familial Intrahepatic Cholestasis 5: Further Evidence for Rapidly Progressive Liver Failure, J. Pediatr. Gastroenterol. Nutr., 70, e111, 10.1097/MPG.0000000000002670 Bull, 1998, A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis, Nat. Genet., 18, 219, 10.1038/ng0398-219 Paulusma, 2006, Rudi de Waart, et al., Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport, Hepatology, 44, 195, 10.1002/hep.21212 Strautnieks, 1998, A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis, Nat. Genet., 20, 233, 10.1038/3034 Wang, 2001, Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis, Proc. Natl. Acad. Sci., 98, 2011, 10.1073/pnas.98.4.2011 Lam, 2005, Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice, Biochemistry, 44, 12598, 10.1021/bi050943e Fuchs, 2017, Metabolic preconditioning protects BSEP/ABCB11(-/-) mice against cholestatic liver injury, J Hepatol, 66, 95, 10.1016/j.jhep.2016.08.017 Smit, 1993, Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease, Cell, 75, 451, 10.1016/0092-8674(93)90380-9 Popov, 2005, Mdr2 (Abcb4)-/-mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro-and antifibrogenic genes, J. Hepatol., 43, 1045, 10.1016/j.jhep.2005.06.025 Wang, 2019, Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2−/− mice, J. Lipid Res., 60, 85, 10.1194/jlr.M088070 Hohenester, 2020, Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis, Cells, 9, 281, 10.3390/cells9020281 Henkel, 2019, Expanding etiology of progressive familial intrahepatic cholestasis, World Journal of Hepatology, 11, 450, 10.4254/wjh.v11.i5.450 Anakk, 2011, Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis, J. Clin. Investig., 121, 86, 10.1172/JCI42846 Dawson, 2005, The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter, J Biol Chem, 280, 6960, 10.1074/jbc.M412752200 Boyer, 2006, Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTα-OSTβ in cholestasis in humans and rodents. American Journal of Physiology-Gastrointestinal and Liver, Physiology, 290, G1124 Li, 2007, Heterodimerization, trafficking and membrane topology of the two proteins, Ost alpha and Ost beta, that constitute the organic solute and steroid transporter, Biochem J, 407, 363, 10.1042/BJ20070716 Gao, 2019, OSTα deficiency: A disorder with cholestasis, liver fibrosis and congenital diarrhea, Hepatology Soroka, 2010, Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis, Hepatology, 51, 181, 10.1002/hep.23265 Rao, 2008, The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis, Proc Natl Acad Sci U S A, 105, 3891, 10.1073/pnas.0712328105 Sultan, 2018, Organic solute transporter-β (SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis, Hepatology, 68, 590, 10.1002/hep.29516 Fabris, 2019, Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases, Nat Rev Gastroenterol Hepatol, 16, 497, 10.1038/s41575-019-0156-4 Isaacs-Ten, 2020, Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability, Hepatology, 10.1002/hep.31228 Dyson, 2018, Primary sclerosing cholangitis, Lancet, 391, 2547, 10.1016/S0140-6736(18)30300-3 Li, 2019, Animal models to study bile acid metabolism, Biochim Biophys Acta Mol Basis Dis, 1865, 895, 10.1016/j.bbadis.2018.05.011 Kennedy, 2020, Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling, Lab. Invest., 1 Zhou, 2019, Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2−/− mouse model of primary sclerosing cholangitis (PSC), EBioMedicine, 48, 130, 10.1016/j.ebiom.2019.09.013 Tardelli, 2019, Monoacylglycerol lipase inhibition protects from liver injury in mouse models of sclerosing cholangitis, Hepatology, 10.1016/S0618-8278(19)30307-X Dropmann, 2020, TGF-β2 silencing to target biliary-derived liver diseases, Gut, 10.1136/gutjnl-2019-319091 de Boer, 2020, A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice, J Lipid Res, 61, 291, 10.1194/jlr.RA119000243 Honda, 2020, Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition, J Lipid Res, 61, 54, 10.1194/jlr.RA119000395 V. Singh B.S. Yeoh B. Chassaing X. Xiao P. Saha R. Aguilera Olvera et al. Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer Cell 175 3 2018 679 694.e22. Kunzmann, 2020, Monocytes as potential mediators of pathogen-induced Th17 differentiation in patients with primary sclerosing cholangitis (PSC), Hepatology, 10.1002/hep.31140 Anstee, 2016, Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease, Gastroenterology, 150, 1728, 10.1053/j.gastro.2016.01.037 N. Chalasani X. Guo R. Loomba M.O. Goodarzi T. Haritunians S. Kwon et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease Gastroenterology 139 5 2010 pp. 1567–1576. e6. Chapman, 2011, Genome-wide association studies in primary sclerosing cholangitis: still more questions than answers?, Hepatology (Baltimore, MD), 53, 2133, 10.1002/hep.24333 Gulamhusein, A.F., B.D. Juran, and K.N. Lazaridis. Genome-wide association studies in primary biliary cirrhosis. in Seminars in liver disease. 2015. Thieme Medical Publishers. Hirschfield, 2013, The genetics of complex cholestatic disorders, Gastroenterology, 144, 1357, 10.1053/j.gastro.2013.03.053 Jiang, 2017, Genetics of primary sclerosing cholangitis and pathophysiological implications, Nat. Rev. Gastroenterol. Hepatol., 14, 279, 10.1038/nrgastro.2016.154 Sookoian, 2020, Genetic pathways in nonalcoholic fatty liver disease: Insights from systems biology, Hepatology, 10.1002/hep.31229 Speliotes, 2011, Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits, PLoS Genet., 7, 10.1371/journal.pgen.1001324 Glaser, 2019, Liver infiltrating T cells regulate bile acid metabolism in experimental cholangitis, J Hepatol, 71, 783, 10.1016/j.jhep.2019.05.030 Guicciardi, 2018, Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice, J Hepatol, 69, 676, 10.1016/j.jhep.2018.05.018 Ferreira-Gonzalez, 2018, Paracrine cellular senescence exacerbates biliary injury and impairs regeneration, Nat Commun, 9, 1020, 10.1038/s41467-018-03299-5 Lin, 2020, Biallelic mutations in DCDC2 cause neonatal sclerosing cholangitis in a Chinese family, Clinics Res. Hepatol. Gastroenterol., 10.1016/j.clinre.2020.02.015 Maddirevula, 2019, Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants, Genet. Med., 21, 1164, 10.1038/s41436-018-0288-x Grammatikopoulos, 2016, Mutations in DCDC2 (doublecortin domain containing protein 2) in neonatal sclerosing cholangitis, J. Hepatol., 65, 1179, 10.1016/j.jhep.2016.07.017 Schueler, 2015, DCDC2 mutations cause a renal-hepatic ciliopathy by disrupting Wnt signaling, Am. J. Human Gene., 96, 81, 10.1016/j.ajhg.2014.12.002 Ünlüsoy Aksu, A., S.K. Das, C. Nelson‐Williams, D. Jain, F. Özbay Hoşnut, G. Evirgen Şahin, et al., Recessive Mutations in KIF12 Cause High Gamma‐Glutamyltransferase Cholestasis. Hepatology communications, 2019. 3(4): p. 471-477. Maroni, 2017, Knockout of the primary sclerosing cholangitis-risk gene Fut2 causes liver disease in mice, Hepatology, 66, 542, 10.1002/hep.29029 Shackel, 2001, Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression, Gut, 49, 565, 10.1136/gut.49.4.565 Arenas, 2019, Promoter hypermethylation of the AE2/SLC4A2 gene in PBC, JHEP Reports, 1, 145, 10.1016/j.jhepr.2019.05.006 Concepcion, 2015, CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a, b−/− mice favoring autoimmune cholangitis, Oncotarget, 6, 28588, 10.18632/oncotarget.5665 Irie, 2006, NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis, J Exp Med, 203, 1209, 10.1084/jem.20051911 Koarada, 2004, Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain, J. Immunol., 173, 2315, 10.4049/jimmunol.173.4.2315 Gorelik, 2000, Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease, Immunity, 12, 171, 10.1016/S1074-7613(00)80170-3 Oertelt, 2006, Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-β receptor II dominant-negative mice, J. Immunol., 177, 1655, 10.4049/jimmunol.177.3.1655 Wakabayashi, 2006, IL-2 receptor α−/− mice and the development of primary biliary cirrhosis, Hepatology, 44, 1240, 10.1002/hep.21385 Xu, 2019, Genetic association of E26 transformation specific sequence 1 polymorphisms with the susceptibility of primary biliary cholangitis in China, Sci. Rep., 9, 1, 10.1038/s41598-019-56181-9 Wang, 2020, Fine mapping of the MHC region identifies major independent variants associated with Han Chinese primary biliary cholangitis, J. Autoimmun., 107, 10.1016/j.jaut.2019.102372 Dong, 2019, Identification of Marker Genes and Pathways in Patients with Primary Biliary Cholangitis, J. Comput. Biol. Maraskovsky, 1996, Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells, J. Immunol., 157, 5315, 10.4049/jimmunol.157.12.5315 Murooka, 2006, CCL5-CCR5-mediated Apoptosis in T cells requirement for glycosaminoglycan binding and CCL5 aggregation, J. Biol. Chem., 281, 25184, 10.1074/jbc.M603912200 Greverath, 2019, Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitis, Hepatology Research, 3, 321 Ibrahim, 2016, Animal models of nonalcoholic steatohepatitis: eat, delete, and inflame, Dig. Dis. Sci., 61, 1325, 10.1007/s10620-015-3977-1 Jiang, 2019, Pathogenesis of and major animal models used for nonalcoholic fatty liver disease, J Int Med Res, 47, 1453, 10.1177/0300060519833527 Lau, 2017, Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances, J. Pathol., 241, 36, 10.1002/path.4829 Sanches, 2015, Nonalcoholic steatohepatitis: a search for factual animal models, Biomed Res. Int., 10.1155/2015/574832 Kannt, 2020, Incretin combination therapy for the treatment of non-alcoholic steatohepatitis, Diabetes Obes. Metab., 10.1111/dom.14035 Friedman, 2018, Mechanisms of NAFLD development and therapeutic strategies, Nat Med, 24, 908, 10.1038/s41591-018-0104-9 Charlton, 2011, Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. American Journal of Physiology-Gastrointestinal and Liver, Physiology, 301, G825 Tsuchida, 2018, A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer, J Hepatol, 69, 385, 10.1016/j.jhep.2018.03.011 Fujii, 2013, A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma, Med Mol Morphol, 46, 141, 10.1007/s00795-013-0016-1 Asgharpour, 2016, A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer, J Hepatol, 65, 579, 10.1016/j.jhep.2016.05.005 Larter, 2008, MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes, J. Hepatol., 49, 407, 10.1016/j.jhep.2008.03.026 Kodama, 2009, c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice, Gastroenterology, 137, 1467, 10.1053/j.gastro.2009.06.045 Miura, 2010, Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice, Gastroenterology, 139, 323, 10.1053/j.gastro.2010.03.052 Lonardo, 2019, Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps, Hepatology, 70, 1457, 10.1002/hep.30626 Handa, 2016, Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice, Am J Physiol Gastrointest Liver Physiol, 310, G117, 10.1152/ajpgi.00246.2015 Arsov, 2006, Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice, Biochem. Biophys. Res. Commun., 342, 1152, 10.1016/j.bbrc.2006.02.032 Denk, 2019, Animal models of NAFLD from the pathologist's point of view, Biochim Biophys Acta Mol Basis Dis, 1865, 929, 10.1016/j.bbadis.2018.04.024 Okumura, 2006, Exacerbation of dietary steatohepatitis and fibrosis in obese, diabetic KK-A(y) mice, Hepatol Res, 36, 217, 10.1016/j.hepres.2006.07.009 Cook, 2001, Peroxisome proliferator-activated receptor alpha-responsive genes induced in the newborn but not prenatal liver of peroxisomal fatty acyl-CoA oxidase null mice, Exp Cell Res, 268, 70, 10.1006/excr.2001.5266 Meyer, 2002, Expression of peroxisome proliferator-activated receptor alpha, and PPARalpha regulated genes in spontaneously developed hepatocellular carcinomas in fatty acyl-CoA oxidase null mice, Int J Oncol, 21, 1175 M. Krawczyk R. Liebe F. Lammert Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond Gastroenterology 158 7 2020 1865 1880.e1. Karrar, 2019, Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease, Medicine, 98, 10.1097/MD.0000000000016704 Liu, J., J. Xing, B. Wang, C. Wei, R. Yang, Y. Zhu, et al., Correlation Between Adiponectin Gene rs1501299 Polymorphism and Nonalcoholic Fatty Liver Disease Susceptibility: A Systematic Review and Meta-Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019. 25: p. 1078. Dai, 2019, Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis, Medicine, 98, 10.1097/MD.0000000000014324 Namjou, 2019, GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE network, BMC Med., 17, 135, 10.1186/s12916-019-1364-z James, 2019, An exploratory phenome wide association study linking asthma and liver disease genetic variants to electronic health records from the Estonian Biobank, PLoS ONE, 14, 10.1371/journal.pone.0215026 Kozlitina, 2014, Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease, Nat. Genet., 46, 352, 10.1038/ng.2901 Aron-Wisnewsky, 2020, Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?, Gastroenterology, 158, 1881, 10.1053/j.gastro.2020.01.049